Hongfan Sun
- Biomaterials top 0.5%
- Nanoparticle-Based Drug Delivery 15
- Pharmaceutical Science top 0.5%
- Advanced Drug Delivery Systems 6
- Biomedical Engineering top 2%
- Nanoplatforms for cancer theranostics 11
- Graphene and Nanomaterials Applications 5
- Molecular Medicine top 5%
- Immunology top 5%
- Immunotherapy and Immune Responses 11
-
- RNA Interference and Gene Delivery 12
-
- Advanced Polymer Synthesis and Characterization 6
-
- Coronary Interventions and Diagnostics 4
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Hongfan Sun
50 papers receiving 3.4k citations
Hit Papers
Peers
Comparison fields: 5 of 121
- Biomaterials 1.6k
- Pharmaceutical Science 432
- Biomedical Engineering 1.4k
- Molecular Medicine 145
- Immunology 577
Countries citing papers authored by Hongfan Sun
This map shows the geographic impact of Hongfan Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongfan Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongfan Sun more than expected).
Fields of papers citing papers by Hongfan Sun
This network shows the impact of papers produced by Hongfan Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongfan Sun. The network helps show where Hongfan Sun may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hongfan Sun, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 95 | |
| 2 | 2019 | 86 | |
| 3 | 2019 | 94 | |
| 4 | 2018 | 14 | |
| 5 | 2018 | 53 | |
| 6 | 2018 | 68 | |
| 7 | 2018 | 42 | |
| 8 | 2018 | 53 | |
| 9 | 2017 | 44 | |
| 10 | 2017 | 42 | |
| 11 | 2017 | 81 | |
| 12 | 2011 | 84 | |
| 13 | 2011 | 20 | |
| 14 | 2009 | 125 | |
| 15 | 2009 | 115 | |
| 16 | 2009 | 200 | |
| 17 | 2008 | 20 | |
| 18 | 2007 | 34 | |
| 19 | 2006 | 48 | |
| 20 | The in vivo degradation, absorption and excretion of PCL-based implantbreakdown → | 2005 | 812 |
About Hongfan Sun
Hongfan Sun is a scholar working on Biomaterials, Pharmaceutical Science and Immunology, having authored 50 papers that have together received 3.5k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (15 papers), RNA Interference and Gene Delivery (12 papers), Immunotherapy and Immune Responses (11 papers), Nanoplatforms for cancer theranostics (11 papers), Advanced Drug Delivery Systems (6 papers), Advanced Polymer Synthesis and Characterization (6 papers), Graphene and Nanomaterials Applications (5 papers) and Coronary Interventions and Diagnostics (4 papers). The work is most often cited by research in Biomaterials (1.6k citations), Pharmaceutical Science (432 citations) and Biomedical Engineering (1.4k citations). Hongfan Sun has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Cunxian Song, Lin Mei, Pengyan Wang, Xiumin Cui, Xigang Leng, Deling Kong, Guilei Ma, Dunwan Zhu, Deling Kong and Chun Wang. Their work appears in journals such as Nano Letters, Biomaterials and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.